EUVIMEDEUVIMED entdecken
Crossref

Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example

Accounting, Auditing and Finance · 2023

DOI: 10.23977/accaf.2023.040107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Accounting, Auditing and Finance, 2023.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2023). Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example. Accounting, Auditing and Finance. https://doi.org/10.23977/accaf.2023.040107

Vancouver

Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example. Accounting, Auditing and Finance. 2023. doi:10.23977/accaf.2023.040107

BibTeX
@article{euvimed2023,
  title = {Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example},
  journal = {Accounting, Auditing and Finance},
  year = {2023},
  doi = {10.23977/accaf.2023.040107}
}
Kostenlos starten →